U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Drug Interactions & Labeling
  6. In the GI Tract
  1. Drug Interactions & Labeling

In the GI Tract

  • Sucralfate, some milk products, antacids, and oral iron preparations
  • Omeprazole, lansoprazole, H2-antagonists
  • Didanosine (given as a buffered tablet)
  • Cholestyramine

 

  • Block absorption of quinolones, tetracycline, and azithromycin
  • Reduce absorption of ketoconazole, delavirdine
  • Reduces ketoconazole absorption
  • Binds raloxifene, thyroid hormone, and digoxin

 

Back to Learning Module

Back to Top